Inventor
TRIVEDI BHARAT K
US34 patents
⚠️ This page may combine multiple inventors who share the name “TRIVEDI BHARAT K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
WARNER LAMBERT CO
31 patentsUS5015644AMay 14, 1991
Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds
WARNER LAMBERT CO77 citations96
US6964983B2Nov 15, 2005
Compounds that modulate PPAR activity and methods for their preparation
WARNER LAMBERT CO37 citations95
US6939875B2Sep 6, 2005
Compounds that modulate PPAR activity and methods for their preparation
WARNER LAMBERT CO51 citations95
US6875780B2Apr 5, 2005
Compounds that modulate PPAR activity and methods for their preparation
WARNER LAMBERT CO60 citations95
US5620997AApr 15, 1997
Isothiazolones
WARNER LAMBERT CO39 citations95
US5593967AJan 14, 1997
Cholecystokinin antagonists, their preparation and therapeutic use
WARNER LAMBERT CO22 citations91
US5331006AJul 19, 1994
Amino acid analogs as CCK antagonists
WARNER LAMBERT CO21 citations90
US6001866ADec 14, 1999
Method for treating and preventing inflammation and atherosclerosis
WARNER LAMBERT CO36 citations88
US7244763B2Jul 17, 2007
Compounds that modulate PPAR activity and methods of preparation
WARNER LAMBERT CO20 citations82
US4683223AJul 28, 1987
N6 -Benzopyrano-and benzothiopyrano adenosines and methods of use
WARNER LAMBERT CO20 citations82
US5116848AMay 26, 1992
N-(((2,6-disubstituted)phenyl)-n-diarylalkyl)ureas as antihyperlipidemic and antiatherosclerotic agents
WARNER LAMBERT CO9 citations74
US5030653AJul 9, 1991
Antihyperlipidemic and antiatherosclerotic compounds and compositions
WARNER LAMBERT CO17 citations74
US4994465AFeb 19, 1991
Antihyperlipidemic and antiatherosclerotic trisubstituted urea compounds
WARNER LAMBERT CO12 citations74
US4868210ASep 19, 1989
Antihyperlipidemic and antiatherosclerotic compounds and compositions
WARNER LAMBERT CO18 citations74
US4780464AOct 25, 1988
(1,2,4)triazolo(4,3-a)quinoxaline-4-amines
WARNER LAMBERT CO11 citations74
US7109222B2Sep 19, 2006
Compounds that modulate PPAR activity and methods of preparation
WARNER LAMBERT CO8 citations73
US6867224B2Mar 15, 2005
Compounds that modulate PPAR activity and methods of preparation
WARNER LAMBERT CO6 citations73
US4614732ASep 30, 1986
N6 -acenaphthyl adenosines and analogs thereof
WARNER LAMBERT CO8 citations73
US4791103ADec 13, 1988
2,N6 -disubstituted adenosines, derivatives and methods of use
WARNER LAMBERT CO17 citations72
US4663313AMay 5, 1987
N6 -tricyclic adenosines for treating hypertension
WARNER LAMBERT CO17 citations72
US4593019AJun 3, 1986
N6 -tricyclic adenosines
WARNER LAMBERT CO13 citations72
US5155127AOct 13, 1992
N-(substituted aryl)-n'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents
WARNER LAMBERT CO5 citations63
US4999373AMar 12, 1991
Antihyperlipidemic and antiatherosclerotic compounds and compositions
WARNER LAMBERT CO3 citations63
US4948806AAug 14, 1990
Antihyperlipidemic and antiatherosclerotic compounds and compositions
WARNER LAMBERT CO4 citations63
US4923896AMay 8, 1990
N-(substituted aryl)-N'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents
WARNER LAMBERT CO5 citations63
US4837207AJun 6, 1989
Diastereoisomers of n6 -endo-bicyclo[2.2.1]heptyladenosine as antihypertensives with selective action
WARNER LAMBERT CO5 citations63
US5118697AJun 2, 1992
Cyclic beta-ketoamide ACAT inhibitors
WARNER LAMBERT CO3 citations62
US4673670AJun 16, 1987
N6 -acenaphthyl adenosines and analogs thereof
WARNER LAMBERT CO2 citations62
US7067538B2Jun 27, 2006
MCP-1 receptor antagonists and methods of use thereof
WARNER LAMBERT CO4 citations61
US5208224AMay 4, 1993
Phosphorus containing compounds as antihypercholesterolemic and antiatherosclerotic agents
WARNER LAMBERT CO4 citations60
USRE39916ENov 6, 2007
Compounds that modulate PPAR activity and methods for their preparation
WARNER LAMBERT CO0 citations48